European Investment Bank

Royal Schiphol Group N.V. is the owner and operator of Amsterdam Airport Schiphol, the national airport of the Netherlands, as well as other airports including Rotterdam The Hague Airport and Lelystad Airport. The company manages and develops airport operations, providing essential services and facilities to airlines, travelers, handling agents, and logistics providers. It also grants concessions for various shops, restaurants, and entertainment options within the airport, while operating its own retail spaces and car parks. Additionally, Royal Schiphol Group develops and manages properties related to airport activities, offering various locations and rental agreements for businesses and logistics service providers. Established in 1958 and headquartered in Schiphol, the company plays a crucial role in aviation and transportation in the Netherlands and beyond.

Samotics is a Dutch technology company that specializes in an AI-powered condition monitoring platform aimed at enhancing the availability of industrial electric motors and rotating equipment. By utilizing data from sensors and operational systems, Samotics' solution offers predictive insights that help companies identify and address potential equipment failures before they occur. This proactive approach enables organizations to reduce unplanned downtime, lower operational costs, and minimize energy waste. The company serves a diverse range of global industrial clients, including notable names such as Anglian Water, ArcelorMittal, and Nobian, helping them optimize their operations and improve the efficiency of their critical equipment.

NXP Semiconductors N.V. is a prominent supplier of high-performance mixed-signal semiconductor products, headquartered in Eindhoven, the Netherlands. Founded in 2006, the company offers a diverse product portfolio that includes microcontrollers, application processors, communication processors, and various wireless connectivity solutions such as Bluetooth, Wi-Fi, and Near Field Communications. NXP's technology is integral to multiple applications across automotive, industrial, Internet of Things, mobile, and communication infrastructure sectors. The company has established a significant presence in the automotive market, providing essential components for powertrains, infotainment systems, and safety systems. Additionally, NXP maintains operations in over 25 countries and has formed strategic partnerships, including collaboration with Amazon Web Services to enhance connected vehicle solutions.

Nyxoah S.A. is a health-technology company based in Mont-Saint-Guibert, Belgium, established in 2009. The company specializes in developing and commercializing innovative solutions for treating sleep disordered breathing conditions, particularly moderate to severe obstructive sleep apnea (OSA). Its primary product, the Genio system, is a user-centered, bilateral neurostimulation therapy that has received CE-Mark validation. OSA is a prevalent condition linked to significant health risks, including increased mortality and various comorbidities such as cardiovascular diseases, depression, and stroke. Nyxoah aims to address these critical health challenges through its advanced therapeutic offerings.

Intrinsic ID B.V. specializes in digital authentication solutions, primarily utilizing its proprietary SRAM Physical Unclonable Function (SRAM PUF) technology. Founded in 2008 and based in Eindhoven, the Netherlands, with operations in Korea, the company develops a range of products aimed at enhancing security for Internet of Things (IoT) and embedded applications. Its offerings include Broadkey, a secure key management software; Citadel, a key provisioning system; Quiddicard, which focuses on remotely programming keys; and Quiddikey, a solution for reconstructing on-chip secret keys without storage. These technologies are designed to validate payment systems, secure connectivity, authenticate sensors, and safeguard sensitive government and military data and systems.

ExeVir Bio BV, founded in 2020 and based in Zwijnaarde, Belgium, specializes in developing single-domain antibody-based therapies aimed at combating viral infections. The company leverages a llama-derived antibody technology platform to create robust antiviral treatments that offer broad protection against coronaviruses. Notably, it is developing VHH72-FC, an antibody that targets a highly conserved region on the spikes of SARS-CoV-2, crucial for the virus's entry into human cells. ExeVir Bio's rapid response platform for antivirals allows for an agile approach to emerging health threats, enabling the swift generation of drug candidates. The therapeutics produced through this innovative technology are designed to be stable, cost-effective, and accessible on a global scale.

LeydenJar Technologies B.V. is a Netherlands-based company founded in 2016 that focuses on enhancing lithium-ion battery performance through the development of pure silicon anodes. By replacing traditional graphite anodes with innovative nanoporous silicon, LeydenJar Technologies significantly increases energy density, achieving a 70% improvement over current standards. This advancement not only leads to batteries with higher energy density of 1350Wh/L but also reduces costs by 20% and lowers the carbon footprint by 85%. The company's commitment to greener, more efficient battery technology positions it as a key player in the energy storage market.

Energiefonds Overijssel is a venture capital firm established in 2012 and located in Zwolle, Netherlands. The company is dedicated to supporting the energy transition by providing financial contributions to initiatives and businesses that focus on energy savings or the generation of energy from renewable sources. Backed by the government, Energiefonds Overijssel prioritizes investments in renewable energy and clean energy technology, aiming to foster sustainable practices and innovation within the energy sector.

Airborne International is engaged in engineering, manufacturing, and supplying high-end composites structures for industries such as aerospace, defense, marine, high-end bicycles, and formula-one cars. It offers composites structures maintenance and repair services, including inspection and damage assessment, sealing and painting, and balancing. The company was founded in 1995 and is based in The Hague, the Netherlands.

DPG Media Group is a media company based in Antwerp, Belgium, specializing in the publication of newspapers, journals, and magazines. It provides a diverse array of news coverage, including entertainment, sports, politics, and market-related stories. In addition to its publishing activities, DPG Media offers advertising services to its clients, catering to a wide audience across Belgium. The company's content encompasses social, scientific, economic, and commercial topics, ensuring a comprehensive approach to media and information dissemination.

miDiagnostics is a Belgian company focused on creating innovative, chip-based technology for self-administered blood analysis. The company is developing a new generation of disposable tests that require only small drops of blood, allowing for the detection of various biomarkers, including cells, proteins, nucleic acids, and small molecules. Their technology integrates a nanofluidic processor on a chip with a compact reader, facilitating lab-quality diagnostics from easy-to-access samples like finger-prick blood or nasal swabs. This approach enables both patients and clinicians to conduct rapid diagnostics conveniently and efficiently, regardless of location.

Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels, utilizing a proprietary polymer-based technology called RestoreX. This technology enables the patient's natural healing system to develop tissue that permeates the heart valve, forming a new functional valve within it through a therapeutic approach called Endogenous Tissue Restoration (ETR). Xeltis' restorative devices include implantable small diameter blood vessels for hemodialysis vascular access and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. The company has secured significant funding from investors such as EQT Life Sciences, Kurma Partners, and the European Investment Bank, totaling over €30 million.

Bone Therapeutics SA is a biotechnology company based in Gosselies, Belgium, that specializes in the development of innovative cell therapy products for orthopedics and bone diseases. Established in 2006, the company has created a robust product pipeline, including ALLOB, an allogeneic cell therapy currently in Phase II clinical trials aimed at treating delayed-union fractures and spinal fusion procedures. Bone Therapeutics also conducts preclinical research on next-generation products, such as combined cell-matrix therapies for large bone defects and maxillofacial applications. The company collaborates with various partners to develop personalized, tissue-engineered bone implants, leveraging its extensive expertise in bone and joint physiology, along with advanced production methods and minimally invasive treatment techniques.

AM Pharma B.V. is a biopharmaceutical company based in Bunnik, the Netherlands, focused on developing and commercializing novel therapeutics for inflammatory and infectious diseases. Established in 2000, the company specializes in pre-clinical and clinical development using endogenous proteins and peptides derived from the human body. Its key products include alkaline phosphatase, aimed at treating acute kidney injury and ulcerative colitis, and the immune response amplifying peptide hLF1-11, which targets drug-resistant hospital-acquired infections. AM Pharma is committed to providing innovative therapies that enhance patient quality of life by addressing critical medical needs.

Azimo, established in 2012, is a London-based digital money transfer company that operates globally. It offers a user-friendly mobile app for sending money internationally, either to bank accounts or over 270,000 cash pick-up points worldwide. Azimo's platform is designed to be fast, secure, and cost-effective, providing an alternative to traditional high street remittance services. It supports both Android and iOS devices, enabling users to transfer funds from any internet-connected device.

ISA Pharmaceuticals B.V. is a clinical-stage immunotherapy company based in Leiden, the Netherlands, established in 2004. The company specializes in developing synthetic long peptide-based therapies aimed at addressing unmet medical needs in cancer and persistent viral infections. Utilizing its proprietary Synthetic Long Peptide (SLP®) platform and AMPLIVANT® technology, ISA Pharmaceuticals designs fully synthetic immunotherapeutics that aim to engage and enhance the body’s immune response against diseases. These innovative therapies are intended to be effective either as standalone treatments or in combination with existing therapies, thereby improving the likelihood of successful patient outcomes.

MotorK is a software as a service (SaaS) provider focused on the automotive retail industry in the EMEA region, employing over 400 staff across eleven offices in eight countries, including Italy, Spain, France, Germany, Portugal, the UK, Belgium, and Israel. The company specializes in developing digital sales and marketing solutions that enhance customer experience for car manufacturers and dealers. MotorK offers a comprehensive suite of integrated digital products and services, including platforms for traffic acquisition, inventory management, sales operations, and promotional campaigns. Key products include WebSparK, a web module known for its technical and design excellence, and StockSparK, a stock management tool that aggregates and enhances inventory visibility for potential buyers. With a strong emphasis on innovation, MotorK boasts one of the largest research and development teams in the European automotive digital sales and marketing sector.

October is a pan-European lending platform that aims to empower businesses by simplifying access to funding. Founded in France in 2014 under the name Lendix, the company emerged following regulatory changes that disrupted traditional banking practices. With offices in France, Spain, Italy, and the Netherlands, October operates an online marketplace that connects private investors with enterprises of various sizes. This platform allows investors to finance businesses directly, offering fully disclosed terms and facilitating a streamlined investment process. Institutional lenders complement individual contributions, ensuring borrowers benefit from high success rates and quick processing times. October's mission is to democratize finance, providing a secure and efficient way for individuals to invest in the real economy.

iZettle AB is a financial technology company based in Stockholm, Sweden, that specializes in mobile payment services and applications designed for small businesses and entrepreneurs. Founded in 2010, it revolutionized the industry with the introduction of the first mini chip card reader, enabling businesses to accept card payments through smartphones and tablets. iZettle offers a range of products, including the iZettle Card Reader Lite and an application compatible with iOS and Android devices, which facilitate payment processing, business management, sales analytics, and customer engagement. The company serves a diverse clientele across several countries, including Sweden, Norway, Denmark, Finland, the United Kingdom, Germany, Spain, Mexico, the Netherlands, and Brazil. As of 2018, iZettle operates as a subsidiary of PayPal Holdings, Inc.